Completed PHASE2 INTERVENTIONAL 2-arm NCT00141908

Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate

Sponsor: American University of Beirut Medical Center

Interventions 17-alpha Hydroxyprogesterone Caproate Castor oil

Updated 5 times since 2017 Last updated: Jul 18, 2013 Started: Oct 31, 2006 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00141908, this PHASE2 trial focuses on Preterm Delivery and remains completed. Sponsored by American University of Beirut Medical Center, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American University of Beirut Medical Center

Data source: American University of Beirut Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beirut, Lebanon